Natalia Jura, PhD

Professor, Department of Cellular and Molecular Pharmacology

Investigator, Cardiovascular Research Institute

University of California San Francisco

Natalia Jura obtained her MS in biochemistry from Jagiellonian University in Krakow, Poland, followed by PhD in molecular and cellular biology from Stony Brook University and postdoctoral training in structural biology at UC Berkeley. She is now a Professor at the Department of Cellular and Molecular Pharmacology and an Investigator at the Cardiovascular Research Institute at UCSF. Dr. Jura’s laboratory aims to understand molecular signals, which allow cells to communicate with each other and respond to environmental stimuli. Her group combines cell biology with structural biology approaches, such as X-ray crystallography and cryo-electron microscopy, to investigate mechanisms of receptor tyrosine kinase signaling, and non-canonical functions of atypical protein kinases, called pseudokinases. For her research accomplishments, Dr. Jura was recently awarded a UCSF Byers Award. In addition to her research activities at UCSF, Dr. Jura serves as an Associate Director of the Quantitative Biosciences Institute at UCSF. In this role, Dr. Jura oversees promotion of interdisciplinary collaborative research at UCSF and beyond.  Dr. Jura is also a co-Director of the UCSF Tetrad graduate program that trains doctoral students towards PhD degrees in cell biology, biochemistry and genetics. Her leadership skills have recently been recognized by the Women in Biochemistry and Molecular Biology Leadership Award from the American Society for Biochemistry and Molecular Biology. Together with her colleagues at UCSF, Dr. Jura recently co-founded a biotech company, Rezo Therapeutics, focused on discovery of new cancer targets via integration of advanced proteomics, genomics, computational and structural biology.

Contact:

Twitter/X: @JuraLab_UCSF